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capsular polysaccharide
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Background: Glycosaminoglycans, such as hyaluronic acid, heparin, and chondroitin sulfate, are among the top
ranked products in industrial biotechnology for biomedical applications, with a growing world market of billion
dollars per year. Recently a remarkable progress has been made in the development of tailor-made strains as
sources for the manufacturing of such products. The genetic modification of E. coli K4, a natural producer of
chondroitin sulfate precursor, is challenging considering the lack of detailed information on its genome, as well as
its mobilome. Chondroitin sulfate is currently used as nutraceutical for the treatment of osteoarthritis, and several
new therapeutic applications, spanning from the development of skin substitutes to live attenuated vaccines, are
under evaluation.
Results: E. coli K4 was used as host for the overexpression of RfaH, a positive regulator that controls expression of
the polysaccharide biosynthesis genes and other genes necessary for the virulence of E. coli K4. Various engineering
strategies were compared to investigate different types of expression systems (plasmid vs integrative cassettes) and
integration sites (genome vs endogenous mobile element). All strains analysed in shake flasks on different media
showed a capsular polysaccharide production improved by 40 to 140%, compared to the wild type, with respect to
the final product titer. A DO-stat fed-batch process on the 2L scale was also developed for the best performing
integrative strain, EcK4r3, yielding 5.3 g∙L-1 of K4 polysaccharide. The effect of rfaH overexpression in EcK4r3 affected
the production of lipopolysaccharide and the expression of genes involved in the polysaccharide biosynthesis
pathway (kfoC and kfoA), as expected. An alteration of cellular metabolism was revealed by changes of intracellular
pools of UDP-sugars which are used as precursors for polysaccharide biosynthesis.
Conclusions: The present study describes the identification of a gene target and the application of a successful
metabolic engineering strategy to the unconventional host E. coli K4 demonstrating the feasibility of using the
recombinant strain as stable cell factory for further process implementations.
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Chondroitin sulfate (CS) is a natural linear polysacchar-
ide formed by disaccharide units of N-acetyl-D-galact-
osamine (GalNAc) and Glucuronic acid (GlcA) β 1:4 and
β 1:3 linked. It is a ubiquitous component of the extra-
cellular matrix of vertebrates where it exerts its
established chondroprotective properties by improving
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reproduction in any medium, provided the orincreasing the viscosity of synovial fluid at disease sites
[1,2]. CS also inhibits cartilage degradative enzymes
therefore it is widely used for the treatment of
osteoarthrithis. Moreover, recent novel studies suggest
its potential applicability for cancer prevention, formula-
tion of skin substitutes, and vaccine development [3-5].
The external coating, defined as capsule, of Escherichia
coli K4 is composed of fructosylated chondroitin and
therefore represents an unlimited source of precursor
supply for the production of CS. Moreover the use of
microbial polymer eliminates the risk of interspecies
viral and prionic contaminations.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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fermentation strategies targeting the maximization of
capsular polysaccharide (CPS) production from E. coli
K4 followed by recovery of a 90% pure polysaccharide
and final chemical sulfation resulting in a polymer that
is equivalent to the extractive counterpart [6-8]. Prod-
uctivity was further increased by overexpressing the en-
zyme responsible for polymer assembly in the wild type
(wt) strain using an inducible plasmid as expression sys-
tem. However, although a 100% improvement in the
final CPS titer was achieved, these experiments also re-
vealed a great genetic instability of the recombinant
strain, that limited process scale-up [9].
The K4 CPS belongs to group II K antigens. Capsules
produced from E. coli K5 and K1 are well studied mem-
bers of this group [10]. The structure of the cluster re-
sponsible for CPS biosynthesis is organised into three
regions. Regions 1 and 3 contain the kps genes common
to all group II members and mainly involved in the
transport of the polymer in the periplasm and outside
the cell wall [11,12]. The genes coding for enzymes that
direct the synthesis and assembly of the final polysac-
charide are found in region 2, that is the serotype spe-
cific. Besides the IS2 insertion sequence, region 2 in E.
coli K4 comprises three genes of unknown function
(kfoB, kfoG, kfoD), kfoE responsible for the addition of
fructose residues [13], kfoA coding for a UDP-glucose 4-
epimerase, kfoF coding for a UDP-glucose dehydrogen-
ase and the well characterised kfoC gene coding for
chondroitin polymerase [14,15].
One of the factors regulating capsule expression is the
transcriptional activator RfaH that carries out an
antitermination process, that also requires the cis-acting
operon polarity suppressor element (ops) located just
upstream of a JUMP start (just upstream of many poly-
saccharide gene starts). The role of the ops element is to
recruit RfaH, and therefore its presence on the nascent
transcript is crucial. Deletion of the ops element results
in fact in the lack of capsule expression in E. coli K5
[16]. The JUMP start sequence is also required for RfaH
to function; indeed it is conserved and present at the 5′
end of RfaH-regulated operons, and it might be neces-
sary to fold the mRNA into stem-loop structures that
mediate these processes [17]. RfaH plays several roles in
E. coli affecting the biosynthesis of lipopolysaccharide
(LPS), O-antigen, and haemolysin, and the production of
the F-factor sex pilus [17]. Its function is to control pro-
moter distal gene expression by preventing the termin-
ation of transcripts and promoting transcription over
long distances. In E. coli K5 RfaH seems to prevent the
termination of region 3 transcripts allowing read
through transcription, and thereby also regulating the
transcription of region 2 [16]. E. coli K5 strains with mu-
tations in the rfaH gene showed undetectable levels ofexpression of region 2 genes, and of the corresponding
encoded proteins. The regulation of transcription of
group II capsule gene cluster is quite complex, also de-
pending on the activity of other regulator proteins
namely H-NS (nucleoid associated protein) and Bip-A
(tyrosine phosphorilated GTPase) that are involved in
the thermal regulation of region 1 and 3 promoters [18].
In the present study an integrative expression cassette
comprising the rfaH gene under the control of part of the
constitutive promoter of the gapA gene, coding for glycer-
aldehyde 3-phosphate dehydrogenase, was constructed
and introduced into wild type E. coli K4. The recombinant
strains overexpressing the regulator demonstrated a sig-
nificant increase of the CPS yield and proved suitable for
the scale up of the fermentation process.
Results
Strain construction
The host E. coli K4 was modified by the addition of extra,
plasmidic or integrative, copies of the rfaH gene. E. coli
K4-pTrcrfaH possesses additional inducible copies of rfaH
on the pTrc plasmid, under the control of the hybrid
promoter consisting of the −10 region from lacUV5 and
the −35 region from trpB. Protein profiles of this strain
grown in shake flask showed an overexpressed band of
about 18 KDa by SDS-Page 3h after IPTG induction and
the intensity of this band slightly increased after 8 and 24h
of growth (data not shown). The sequence of the rfaH PCR
product cloned in the pTrc plasmid was compared to that
of E. coli K12 and silent point mutations, three transitions
and three transversions, were identified (Additional file 1).
EcK4r1 and EcK4r3 were generated by the integration of a
fragment containing the rfaH gene under the control of the
P1 portion of the gapA promoter, targeting the endogenous
plasmid pK4EC05 and the lacZ gene, respectively. The ex-
pression cassette also comprised the kanamycin resistance
gene flanked by FRT sites that allowed the removal of the se-
lection marker by means of a consecutive pop-out step,
resulting in resistance-free strains.
Shake flask experiments
Direct comparison of the three recombinant strains was
performed in shake flask conditions on the control
medium [19] to investigate physiological differences
resulting from (i) an increased copy number of the rfaH
gene (ii) the different expression systems used, and (iii)
integration targeted to endogenous plasmid or genome
(strains EcK4r1 and EcK4r3, respectively). All recombin-
ant strains demonstrated a significant increase of CPS
production after 24h of growth together with a higher
YK4/X, thereby clearly demonstrating the positive effect
of a higher availability of RfaH on CPS production
(Table 1). E. coli K4-pTrcrfaH was used in this study
only as a tool to evaluate whether rfaH overexpression
Table 2 Hydrolysis of the K4 CPS produced during shake
flask experiments
pH=5 pH=6
Time K4 Defructosylated K4 Defructosylated
(h) (mg∙L-1) (mg∙L-1) (mg∙L-1) (mg∙L-1)
3 189 27 199 17
6 181 35 198 18
16 162 54 192 24
The polysaccharide (216 mg∙L-1) was incubated in the standard growth
medium at pH=5 and pH=6 without cells for 16h. The temperature was kept
constant at 37°C and agitation was set to 200 rpm. Samples were collected
after 3, 6 and 16h of incubation to analyse defructosylation over time.
Table 1 Summary of growth, K4 CPS production and relative yields obtained in shake flask experiments from the
reference E.coli K4 and the recombinant strains
Strain Carbon/
Nitrogen
Biomass μmax K4 YK4/X YK4/S
(gcdw∙L-1) (h-1) (mg∙L-1) (mg∙gcdw-1 ) (mg∙g-1)
E.coli K4 Gly/Soy 2.24 0.88 124 55 11
E.coli K4-pTrcrfaH Gly/Soy 2.08 0.67 294 140 -
EcK4r1 Gly/Soy 2.49 0.76 174 70 -
EcK4r3 Gly/Soy 2.39 0.77 212 88 20
E.coli K4 Glu/Ye 2.89 1.03 190 66 18
EcK4r3 Glu/Ye 2.83 1.05 283 100 27
The concentration of capsular polysaccharide was measured in the broth at the end of the experiment after 24 h of growth. YK4/X indicates mg of K4 CPS
produced per g of dry cells. YK4/S indicates mg of K4 CPS produced per g of carbon source consumed. μmax indicates the maximum specific growth rate in h
-1.
The values are averages of at least 4 separate experiments with a standard deviation below 10%. Abbreviations: Glu (Glucose), Gly (Glycerol), Ye (Yeast extract).
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2.4-fold higher concentration of polysaccharide was in
fact obtained with a 155% increase of the YK4/X; a
slightly lower growth rate and biomass production com-
pared to the wild type strain was probably due to the
higher metabolic burden.
The performance of integrative recombinants EcK4r1
vs. EcK4r3 was quite different in terms of final total
polysaccharide produced and yield over biomass. As
shown in Table 1 the percentage of increase of both
polymer and YK4/X at the end of the growth, compared
to the wild type strain, was almost two fold higher for
EcK4r1 versus EcK4r3.
When testing E. coli K4 and EcK4r3 on a new medium
containing glucose and yeast extract, an increase of
biomass and K4 CPS was observed. Furthermore, also
the yield of K4 CPS per gram biomass increased on the
new medium for both strains, indicating a decoupling of
polysaccharide and biomass formation (Table 1).
EcK4r3 cultivations also showed the decrease of pro-
duction of fructosylated biopolymer from 14 to 1% and
the drastic reduction of the pH24h from 6.4±0.28 (on
the standard medium) to 5.2±0.14. In order to verify
that the additional copies of rfaH did not modify the ag-
gressiveness of EcK4r3, a MIC test was performed. In
particular the antimicrobial resistance of EcKr3 was
compared to that of the wild type strain by using a com-
mercial kit. Results did not highlight any difference be-
tween the two strains.
Hydrolysis of the K4 CPS
A partial defructosylation of the K4 CPS was obtained
after the incubation at pH=5 and pH=6 in conditions
simulating growth in shake flasks but without cells
(Table 2). In particular at pH=5 the percentage of
defructosylated polymer increased from about 12.5%
after 3h of incubation to 25% at the end of the process.
Defructosylation was less pronounced when incubating
the polymer at pH=6.Analysis of gene expression
Quantitative real time PCR was used to analyse the level
of expression of the rfaH gene in EcK4r3 grown on the
medium containing glucose and yeast extract to investi-
gate its expression levels and establish whether the pres-
ence of additional gene copies also affected RNA
expression profiles of the kfoA and kfoC genes. Samples
from shake flasks were collected during early exponential
and mid to end stationary phases. Expression was
normalised on the 16S rRNA. The overexpression folds
are shown in Figure 1. The expression of all genes in-
creased during growth in EcK4r3 compared to the wild
type but, as expected, the increment of rfaH mRNA
pools was higher compared to that of kfoC and kfoA
transcripts.Batch experiments in 2L bioreactors
Twenty-six hours batch growths were conducted to ana-
lyse the physiology of strain E. coli K4-pTrcrfaH, how-
ever, results were completely opposite from those
expected after shake flask experiments. The amount of
K4 CPS produced was on average 190 mg·L-1, almost
40% lower compared to that obtained from cultivating
the reference strain in the same conditions. A growth
defect and the loss of recombinant plasmid already after
Figure 1 Analysis of rfaH, kfoC and kfoA gene expression in E.
coli K4 and EcK4r3 in shake flask experiments. Histogram
representing the fold overexpression of the genes under
investigation in the recombinant strain EcK4r3 compared to the wild
type E.coli K4.
Figure 2 Time course of 24h batch fermentations on the
control medium: comparison of strains EcK4r1 and EcK4r3. (a)
Production of biomass and K4 CPS (b) Consumption of glycerol and
production of total acids throughout the process.
Table 3 Intracellular concentrations of UDP-Glu, UDP-
GlcA and UDP-GalNAc in E.coli K4 (wt) and EcK4r3 during
batch experiments
E.coli K4 (wt) EcK4r3
μmol∙gcdw-1 μmol∙gcdw-1
5h UDP-Glu 0.56 11.3
UDP-GlcA 0.42 0.11
UDP-GalNAc 3.77 1.63
8h UDP-Glu 1.92 5.64
UDP-GlcA 1.33 0.82
UDP-GalNAc 0.61 0.51
24h UDP-Glu 1.96 0.37
UDP-GlcA 1.85 1.93
UDP-GalNAc 0.07 0.05
Samples were collected after 5, 8 and 24h of growth. Experiments were
performed in duplicate and the standard deviation was ≤ 15%.
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explaining the low YK4.
Batch experiments comparing strains EcK4r1 and
EcK4r3 on the control medium are shown in Figure 2
(a-b). The final titer of polysaccharide in the supernatant
was higher by 34 and 55% compared to results obtained
with E. coli K4 in the same growth conditions. EcK4r1
showed a lower growth, glycerol consumption and acid
production rate (Figure 2b) compared to EcK4r3 and the
concentration of total acids accumulated by the end of
the process was higher. CPS production levels reached
402±20 and 466±25 mg·L-1,for EcK4r1 and EcK4r3,
respectively.
The behaviour of EcK4r3 in the medium containing
glucose and yeast extract was also analysed. Compared
to the control medium only a slightly higher growth and
carbon source consumption rate were observed, whereas
the yield of K4 on biomass was unaffected. After 6h of
growth the carbon source was exhausted, 4.2 gcdw·L
-1 of
biomass and 260 mg·L-1of K4 CPS were produced; the
latter however doubled by the end of the process (24h)
determining a final concentration of 532±30 mg·L-1of
polysaccharide. The concentration of cell-bound and re-
leased LPS after 24h of growth was equal to 0.005 and
0.16 g·gcdw
-1 , respectively. Comparing the data to that
obtained from the wild type strain a 1.58 and 1.55-fold
increase were obtained for the two LPS fractions demon-
strating the effect of rfaH overexpression on LPS
production.
A hot methanol extraction method was used to deter-
mine the UDP-sugar precursors' content in fermentation
samples by capillary electrophoresis. In particular biomass
samples for the wt E. coli K4 (fermentation data not
reported) and recombinant strain EcK4r3 after 5, 8 and
24h of growth were collected and analysed to identifyeventual differences in UDP pools (Table 3). UDP-GlcA
increased over time in both strains reaching after 24h a
quite similar concentration of μmoles per gcdw; conversely,
a 3.8 and 1.6-fold higher amount of sugar nucleotide is
present in the wt after 5 and 8h of growth, respectively.
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creases in the recombinant and wt strains; also in this case
the precursors’s pool seems to be richer in the wt strain
(2.3-fold higher) after 5 h of growth whereas more similar
concentrations in the two strains are noticed after 8 and
24 h. Finally, E. coli K4 and EcK4r3 greatly differ for the
content of intracellular UDP-Glucose (UDP-Glu) that
shows opposite growing trends in the two strains, and
quite diverse concentrations (Table 3).
DO-Stat fed-batch experiment
EcK4r3 was analysed in fed-batch fermentations using a
DO-stat feeding strategy in order to meet the strain’s
metabolic requests thus keeping overflow metabolism
under control. On average within 49.5h of process the
cell density reached 21.7±1.7 gcdw∙L
-1 and 5.1±0.2 g∙L-1
of K4 CPS were attained (Figure 3). Compared to batch
experiments on the same medium the YK4/X increased
from 0.13±0.01 to 0.23±0.01 gCPS∙gcdw
-1 whereas the YX/S
decreased from 0.42±0.03 to 0.164±0.026 gcdw∙gS
-1.
Discussion
Several microbial strains representing natural sources of
GAG and GAG-similar molecules have so far been iso-
lated and a great progress concerning the improvement of
yields through the optimization of fermentation strategies
was recently described [6,20]. Besides classical process
optimization also genetic engineering of the strain is cru-
cial for improving the efficiency of natural hosts. The so
far reported metabolic re-tooling strategies mainly focused
on increasing the supply of sugar precursors and of en-
zymes responsible for chain polymerization [6].
The transcription of region 2 of the CPS cluster of
group II E. coli, that includes E. coli K4, is driven by a
promoter located just downstream of region 3, conse-
quently region 2 and 3 genes are transcribed as a singleFigure 3 Production of K4 CPS in 2L DO-Stat fed-batch experiments. TimmRNA unit. Expression of group II K antigens requires
the presence of the RfaH factor having the role of
antiterminator thus providing transcription of promoter
distal genes [21]. Previous work has indicated that loss
of the RfaH protein in group II E. coli results in the de-
creased expression of region 2 genes [16] and K capsule
[22]. It was therefore interesting to investigate whether,
conversely, protein overexpression could lead to an in-
crease in capsular polysaccharide production. At first the
recombinant plasmid pTrc-rfaH containing the rfaH
gene under the control of the Trc inducible promoter
was introduced into E. coli K4 cells. Cells harbouring the
above mentioned construct produced a protein of the
expected molecular weight that increased over time in
shake flask experiments and a significant increase in
polysaccharide production was obtained after 8h and
24h of growth. The E. coli K4-pTrcrfaH recombinant
strain only served as a proof of principle to determine
whether the increased availability of RfaH would trigger
CPS production. In fact, as already found previously for
a similar expression construct [9], also in this case a se-
vere loss of recombinant plasmid was observed in fer-
mentation conditions thereby harshly affecting the
productivity of the process. This finding therefore con-
firms that conventional plasmid driven expression con-
structs are suitable for investigating possible metabolic
engineering targets in shake flasks but do not allow the
scale up of the process with E. coli K4.
An expression cassette containing the rfaH gene under
control of the P1 partial constitutive promoter of the
glyceraldehyde-3-P dehydrogenase was designed and
used to obtain integrative strains. As previously demon-
strated E. coli K4 possesses an endogenous mobile elem-
ent indicated as pK4EC05 that is stably inherited and
shows homology to large conjugative plasmids [9].
pK4EC05 and the genome were used as integratione course of biomass, polysaccharide production and residual glucose.
Figure 4 Relative changes of K4 CPS, biomass, and yields on
different media for EcK4r3 and E.coli K4 (wt). Percentages in
boxes with the same grey tone are referred to the combination of
strain and medium indicated with ref (equal to 100%). Abbreviations:
Glu (Glucose), Gly (Glycerol), Ye (Yeast extract).
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EcK4r3, respectively, to investigate whether the integra-
tion site could have an impact on improving CPS pro-
duction. Results clearly show that growth of EcK4r1 and
EcK4r3, and biomass formation were not affected by the
introduction of recombinant DNA. Both strains demon-
strated a significantly higher amount of polysaccharide
in shake flask experiments on the control medium com-
pared to the wt. A better performance was obtained
from EcK4r3 that almost reached the titer produced
from E. coli K4-pTrcrfaH. One major goal of this study
was to investigate the stability of the newly constructed
recombinant strains, a key feature in the attainment of
master and working cell banks for biopharmaceutical ap-
plications. When shifting from shake flask to fermenter
experiments the YK4/X for the wild type strain improves
by 50%, specifically from 55 to 82mgCPS·gcdw
-1 [19]. The
same YK4/X percentage increase was obtained when scal-
ing up the batch process for EcK4r1 and EcK4r3. Also
the YK4/X percentage increment for the two recombinant
strains observed in shake flask experiments, in compari-
son to the wild type, was maintained in fermenter exper-
iments (60% for strain EcK4r3 and 30% for strain
EcK4r1). This conserved behaviour under the two differ-
ent cultivation conditions is clearly demonstrating strain
stability and overcomes the previously described prob-
lems. The development of biotech processes is often hin-
dered by the use of hosts harbouring recombinant
plasmids that can trigger stress responses that finally
limit biomass and product yield, as observed for E. coli
K4-pTrcrfaH. Similar restraints were not encountered
for strain EcK4r1; as a matter of fact we observed that
this endogenous element can host foreign DNA and
keep it over generations and time, confirming its key im-
portance for strain survival and it’s suitability for
targeted gene integrations.
Fermentation experiments on the control medium in
which the physiology of the integrative strains was stud-
ied confirm the superior performance of EcK4r3. Data
highlighted a slightly faster growth for the latter that is
reflected into the steeper substrate consumption and
corresponding acid production rates. The significantly
higher concentration of total acids (>25%) produced by
EcK4r1 suggests a different carbon distribution which
might influence the entire CPS biosynthesis process,
resulting in a lower concentration of polymer. However,
a key role might also be played by the number of gene
copies integrated in the recombinant strains and by the
integration site itself.
The use of glycerol as main carbon source in industrial
microbiology is advantageous due to its low cost and
handling ease. Nevertheless glucose is often preferable in
large scale fed-batch fermentation processes. In this per-
spective an alternative medium containing glucose asmain carbon source was evaluated. Also soy peptone,
the main nitrogen source, was replaced by yeast extract
that better supported growth and CPS production. A
comparison of growth and CPS production for EcK4r3,
the best performing integrative strain, and the wild type,
on the two media under analysis is schematically repre-
sented in Figure 4. Considering all parameters studied
best performances for both strains were obtained in the
medium containing glucose and yeast extract. However,
interestingly, the potential of the recombinant strain
seems to be more expressed on the control medium
since the improvement of all yields is higher, maybe indi-
cating the occurrence of a certain type of limitation.
Moreover the increment of biomass, K4 CPS, and rela-
tive yields observed for the wt strain following medium
substitution, is lower for EcK4r3 further supporting the
previous hypothesis. This may indicate that CPS produc-
tion is subjected to various control levels one of which is
RfaH-dependent, whereas the others controlled by
medium components. Nevertheless, EcK4r3 demon-
strated a yield of polysaccharide (mg·(gcdw·gsubS)
-1) in
batch experiments on this medium never described be-
fore, that is similar to that obtained with hyaluronic
acid-producing Streptococcus strains [23,24] already used
for industrial manufacturing processes. Compared to
growth on the standard medium containing glycerol as
the main carbon source we observed both for the wild
type and for EcK4r3 an increase in the production of
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are present in the medium. Growth of both strains on
the standard medium generates a final pH of about 6.4
whereas on the richer medium due to the higher amount
of acids produces the pH is around 5. Chemical hydroly-
sis experiments of the K4 CPS in conditions simulating
growth for 16h at pH 5 and 6 demonstrated a partial hy-
drolysis of the polysaccharide that is about 2-fold more
pronounced at the lower pH. We therefore suggest that
this might be one of the causes responsible for the pres-
ence of a polymer that is mostly defructosylated. How-
ever, probably several concurrent phenomena contribute
to the production of mainly defructosylated polymer.
For example since the growth and carbon consumption
rates of both strains are higher on glucose another cause
may be attributed to kinetic differences between polyme-
rization and fructosylation and also to the channelling of
fructose towards the synthesis of GalNAc that may also
contribute to explaining the data observed.
To further improve the concentration of polysacchar-
ide produced, a fed-batch process using a DO-stat feed-
ing approach was developed. This technique allowed to
satisfy the strain’s metabolic demand avoiding cell star-
vation or the accumulation of excess carbon thereby
reaching the highest titer of K4 CPS produced through
fermentation experiments up to date (5.3 g∙L-1). Com-
pared to batch experiments on the same starting
medium the amount of K4 CPS produced by EcK4r3 in-
creased by 10-fold. Moreover growth conditions in fed-
batch/DO-stat mode seemed to promote polysaccharide
production to the detriment of biomass, since a 1.8-fold
higher YK4/X was observed whereas the YX/S decreased
by 2.6-fold compared to batch experiments.
Previous fermentation experiments on the wild type E.
coli K4 performed by our group showed a significant im-
provement of the final K4 CPS concentration by using a
membrane bioreactor combined with a fermentation
strategy based on in situ product removal [25]. ECK4r3
would allow the use of well scalable fed-batch processes
that do not require additional devices inside the fermen-
tation vessel, which would be a step towards the actual
production-scale of tons per year of chondroitin sulfate.
In order to investigate the increased availability of the
antiterminator at the transcriptional level, the expression
of rfaH in EcK4r3 was investigated through qPCR to ana-
lyse the impact of the additional pgapA regulated copy/ies
on its expression. In particular the P1 site of the
multipromoter system was used in this study [26]. As
expected a significative increase of the rfaH mRNA pool
was observed throughout growth with a peak after 24h.
Stevens and coworkers [16] demonstrated that RfaH does
not directly increase the initiation of region 2 transcripts
whereas it supports their activity to obtain adequate levels
of expression of the genes that are required to synthesizethe K5 capsular polysaccharide. We analysed the expres-
sion of two genes belonging to region 2, namely kfoC and
kfoA. Both genes were positively affected by rfaH
overexpression without significative differences among the
two transcripts. RfaH regulates bacterial operons engaged
in the production of also other extracellular components
involved in the virulence of pathogens such as the LPS,
α-haemolysin toxin and F pilus. In fact, deletion of rfaH
abolished the virulence of uropathogenic E. coli due to
downregulation of several virulence factors [22]. To fur-
ther deepen the study, production of cell-bound and re-
leased LPS in EcK4r3 was also investigated. The same
CPS to LPS ratio observed for the wild type strain (2:1) is
conserved in EcK4r3, although the latter demonstrates a
1.5/1.6-fold increase of both the cell-bound and released
LPS portions, in accordance with the increment of K4
CPS production. These results clearly demonstrate the
broader effect of rfaH overexpression.
A higher production of capsular polysaccharide, as in
EcK4r3, does not necessarily imply a variation in the
concentration of intracellular pools of precursor UDP-
sugars; the former could in fact be due to a higher flux
through the pool. However, it was interesting to find that
rfaH overexpression affected both concentration values
and time course profiles of UDP-Glu, UDP-GalNAc and
UPD-GlcA, analysed in this work. The major difference,
compared to the wt strain, regarded UDP-Glu. Wu and
co-workers [27] cultivating Lactobacillus casei found an
increase in the abundance of enzymes responsible for
the biosynthesis of UDP-Glu and of precursor sugar-
nucleotides for the synthesis of exopolysaccharides, in
the early stationary phase. A similar trend was observed
for the wt E. coli K4, whereas in EcK4r3 not only the
intracellular concentration of UDP-Glu decreased to-
wards the end of growth, but a 20-fold higher concentra-
tion compared to the wt, was observed when growth
slowed down (5h). kfoF, belongs to region 2 and codes
for a UDP-glucose dehydrogenase that converts UDP-
Glu into UDP-GlcA. The induction of the gene, due to
rfaH overexpression, might have increased the need for
UDP-Glu that is an essential intermediate also for other
biosynthesis processes (eg. Biosynthesis of cell wall com-
ponents), so that the metabolism responded by increas-
ing the available pool of this substrate. In both strains
UDP-GlcA and UDP-GalNAc exhibited the same trends
over time, however a lower intracellular availability of
both sugar-nucleotides, that is most pronounced after
5h of growth, was observed in EcK4r3 compared to the
wild type which might mirror the higher polysaccharide
production rate of the recombinant strain. Overall rfaH
overexpression seems to affect the intracellular concen-
tration of UDP-sugar precursors further supporting an
extensive metabolic response at least regarding the path-
ways involved in polysaccharide biosynthesis.
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Overall in the present work a new engineered chondro-
itin production host was constructed by introducing
additional copies of the rfaH gene in the unconventional
strain E. coli K4. Homologous overexpression of the
gene not only improved CPS production in shake flasks
but also increased the final titer of polysaccharide in fer-
menter experiments in batch and fed-batch mode,
thereby proving the possibility of achieving stable inte-
grations in this peculiar capsulated strain. Furthermore
the construct developed in this work does not require
induction by IPTG or selection pressure (e.g. antibiotics)
during the cultivation which makes the foreseen produc-
tion process cheaper and reduces the impact on the en-
vironment. This work also shows that the know how
acquired with studies carried on the wild type, and the
fermentation processes developed, can be easily trans-
ferred to genetically engineered strains simplifying the
approach towards the set up of large scale biotech pro-
duction processes. A global overview of the results
obtained in the present work is depicted in Figure 5.
Materials and Methods
Medium
The standard medium used for all shake flask and fer-
menter production studies consisted of a defined saltsFigure 5 General overview on the effect of inserting additional copie
higher production of capsular polysaccharide that is probably due to an in
the mRNA levels of kfoA and kfoC were analysed in this study. The figure a
production.medium (KH2PO4 2 g∙L
-1; K2HPO4 9.7 g∙L
-1; Na3C6H5O7
0.5 g∙L-1; (NH4)2SO4 1 g∙L
-1; MgCl2 0.1 g∙L
-1) sup-
plemented with glycerol or glucose (10 g∙L-1) as the main
carbon source and neutralised soy peptone (1 g∙L-1) or
yeast extract (2 g∙L-1), respectively, as additional nitrogen
source (Oxoid). Luria-Bertani (LB) medium was used dur-
ing transformation experiments. Transformed cells were
grown on LB medium supplemented with ampicillin or
kanamycin (50 μg∙mL-1). The wild type strain used in all
experiments was E. coli K4 serotype O5:K4:H4 (CCUG
11307), purchased from the Culture Collection University
of Göteborg.
Materials
Genomic DNA, plasmid DNA, and RNA were isolated
using Qiagen DNeasy kit, Qiagen miniprep kit, Qiagen
RNeasy kit (Qiagen, Valencia, CA) respectively according
to the manufacturer’s instructions. Restriction endo-
nuclease digestions, DNA ligations, SDS-PAGE and
agarose gel electrophoresis were performed using stand-
ard techniques [28].
Construction of the rfaH overexpressing strains
Primers used for the construction of strains described in
this study are reported in Table 4. Amplification of the
rfaH gene and of the P1 gapA promoter for thes of rfaH in E.coli K4. It shows that overexpression of rfaH leads to
crease of expression of the genes belonging to region 2; in particular
lso indicates that rfaH overexpression increases lipopolysaccharide
Table 4 Sequences of the primers used for constructing
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chromosomal DNA. Primers for the amplification of the
gene and of the promoter were designed based on the se-
quence of rfaH and pgapA of E. coli K12 present in the
database. Polymerase chain reaction (PCR) was carriedFigure 6 Schematic representation of the integration cassette used foout with Expand High fidelity PCR System (Roche,
Monza, Italy) according to the manufacturer’s protocol.
DNA fragments were recovered from agarose gels using
the Qiaquick gel extraction kit (Qiagen, Valencia, CA). Re-
striction endonucleases were purchased from New
England Biolabs and ligases were purchased from
Invitrogen (Carlsband, CA). Nucleotide sequencing of all
PCR fragments cloned was carried out at BMR Genomics
(Padova, Italy) to verify that the sequences were correct.Strain E. coli K4-pTrcrfaH
rfaH was TA-cloned into pTrcHis (Invitrogen) not in
frame with the N-terminal his tag contained in the
vector. The forward primer contained a stop codon and
a new ribosome binding site. Primers used for the ampli-
fication are rfaHpTrc1 and rfaHpTrc2 (Table 4).Strain EcK4r1- EcK4r3
The recombinant strains EcK4r1 and EcK4r3 were
constructed using the Gene deletion kit (Gene Bridges).
The provided integration cassette was modified by the
addition of the rfaH gene under the control of the
gapA promoter just downstream of the kanamycin gene
(Figure 6). E. coli K4 wt chromosomal DNA was used as
template for the amplification of the glyceraldehyde-
3-phosphate dehydrogenase promoter and the rfaH gene.
All primers used for strain construction are reported in
Table 4. A scheme of the resulting cassette is depicted in
Figure 6. The pK4EC05_Up and pK4EC05_Dw oligos con-
tain a 50bp region similar to the 5' and 3′portion of the
PK4EC05 plasmid, respectively, to target the recombin-
ation event for the construction of strain EcK4r1.
The cassette used for the achievement of strain
EcK4r3 was amplified with primers LacZ_Up and
LacZ_Dw containing 100bp region similar to the 5' andr the construction of EcK4r1 and EcK4r3.
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get the recombination event.
Transformation
For the construction of all strains E. coli K4 electro-
competent cells were prepared according to the instrument
instructions and transformed through electroporation
using a Bio-Rad Gene Pulser (2mm cuvettes, 2.5 kV, 200
Ω, 25 μF). E. coli K4 was transformed with the vector
pTrc-rfaH and plated on LB plates supplemented with
50 μg·mL-1 ampicillin to select for positive clones. Strains
EcK4r1 and EcK4r3 were obtained following the instruc-
tions of the kit.
Strain characterization
The Minimum Inhibitory Concentration (MIC) of antibi-
otics, antifungal and antimycobacterial agents was
established by performing the EtestW (BioMerieux Italia S.
p.a.). Etest consists of a predefined gradient of antibiotic
concentrations on a plastic strip and it was used to com-
pare E. coli K4 and EcK4r3. The analysis was performed
by the group of Prof. Donnarumma at the Department of
Microbiology, Second University of Naples.
Gene expression
Quantitative real-time PCR was performed on E. coli K4
wild type and EcK4r3 recombinant strains to compare
the mRNA levels of the genes of interest.
Three time points were chosen for analysis corre-
sponding to 3, 8 and 24h of growth. RNA was treated
with DNase using the DNA-free kit following the sup-
plied protocol (Ambion Inc Austin, TX) and 500 ng
were used for reverse transcription with the Reverse
Transcription System (Promega, Madison, USA). PCR
amplification was performed in an iQ5 instrument
(Biorad California, USA). The 16S rRNA was used to
normalise expression of rfaH, kfoC and kfoA genes. The
primers used for the experiment are reported in Table 4.
Amplification was carried out in 25 μL containing 5 μL
cDNA, 12.5 μL of iQ Syber Green Supermix (Biorad,
California, USA) and 0.5 μL of each primer at a concentra-
tion of 0.4 μM. After incubation at 95°C for 3 min,
amplification proceeded with 40 cycles of 95°C for 10 s
and 62°C for 1 min. The efficiencies of the primer sets
were measured using a dilution series of cDNA. The raw
threshold cycle (Ct) values were converted to relative ex-
pression levels by the 2(−ΔΔCt) method [29]. Three bio-
logical samples each in triplicate were analysed for every
timepoint in the wild type and recombinant strains.
Shake flask experiments
Shake flask experiments were performed in order to
evaluate the effect of rfaH gene overexpression on the
production of K4 polysaccharide. Before each experimentcells from 20% (w/v) glycerol stock preparations were
streaked on agar plates and grown overnight (o/n) at 37°C.
Single colonies were then used to inoculate pre-cultures
that were incubated o/n at 37°C in shaking conditions.
The medium used for all shake flask production stud-
ies is described in the medium section. For strain E. coli
K4-pTrcrfaH 100 μg∙L-1 ampicillin were supplemented
before each experiment.
For all experiments 200 mL cultures of wild type and
recombinant E. coli K4 were grown in 1 liter baffled
flasks, keeping a 1:5 medium/air volume ratio, at 37°C
and 200 rpm in a rotary shaker incubator (model
Minitron, Infors, Bottmingen, Switzerland). For the
strain E. coli K4-pTrcrfaH the cultures were grown until
the OD600 reached 0.7 and at that point 0.4 or 1 mM β-
isopropylthiogalactoside (IPTG) was added to the broth.
Strains EcK4r1 and EcK4r3 were grown for 24h with-
out the addition of antibiotic and inducer. Samples were
withdrawn during the course of the experiment to ana-
lyse polysaccharide production. Every shake flask experi-
ment was repeated at least four times.
Fermentation experiments
Fermentation experiments were carried out as biological
triplicates in a Biostat CT reactor (Sartorius Stedim;
Melsungen, Germany), 2 L working volume. A constant
pH of 7.5 was maintained via automated addition of 30%
v/v NH4OH and 30% v/v H2SO4.
Seed cultures were prepared by inoculating a single
colony in 200 mL of medium in 1L baffled shake flasks.
The flasks were incubated overnight at 37°C and 200
rpm. For the duration of all cultivations 5 mL samples
were withdrawn from the reactors at regular time inter-
vals for the determination of substrates, extracellular
metabolites and polysaccharide quantification.
For batch experiments the concentration of dissolved
oxygen (DO) was maintained above 20% varying the air
flow rate (1–1.5 L∙min-1) and stirring rate (200–800
rpm) according to oxygen demand. The media used for
all experiments were that described in the medium sec-
tion. For the strain E. coli K4-pTrcrfaH 100 μg∙L-1 ampi-
cillin were added to the medium before each experiment
and the cultures were grown until the OD600 reached 0.7
and at that point 0.4 or 1 mM β-isopropylthiogalactoside
(IPTG) was added to the broth.
For fed-batch experiments cells were grown in the
semidefined medium containing glucose and yeast ex-
tract. A DO-Stat controlled feeding strategy with a pO2
set point equal to 35% of air saturation was used. After
the batch phase, a concentrated nutrient solution (450
g∙L-1 glucose and 90 g∙L-1 yeast extract, inorganic salts
20-fold concentrated) was fed to the culture in the fol-
lowing 42.5h of growth.
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The biomass obtained from fermenter experiments was
suspended in 90% v/v pre-warmed phenol. A volume of
pre-warmed water was then added to the suspension
and incubated for 30 minutes at 68°C in stirred
conditions.
The solution was then centrifuged at 9000xg for 30
minutes at 4°C and the upper phase containing the LPS
was extracted and preserved. This procedure was re-
peated for three times. The three fractions recovered
were dialyzed against water (6000–8000 Da membranes)
for two days. The upper phase was further treated for
the quantification of the O-chain. Hydrolysis was
performed adding 1% v/v acetic acid to the solution that
was then incubated for 1.5 h at 100°C. The sample was
then centrifuged at 9000xg, at 4°C for 30 minutes and
the supernatant was analyzed through capillary electro-
phoresis as described in the following section (Quantifi-
cation of CPS, LPS and UDP-sugars)
UDP-sugar extraction
UDP-sugars were extracted from biomass samples by
slightly modifying the method reported by Maharjan and
Ferenci [30]. Briefly, broth samples corresponding to
about 0.8 mgcdw were cooled at 0°C in an ice-water bath
and immediately centrifuged at 16000xg and 0°C for 5 mi-
nutes. Pellets were resuspended in 1mL of 50% v/v metha-
nol and incubated at 70°C for 30 minutes. The
supernatant was recovered by centrifugation and concen-
trated in a vacuum centrifuge to 70 μl for capillary electro-
phoresis analysis as described in the following section.
Hydrolisis of the K4 CPS
The K4 CPS produced in shake flask cultivations was used
for an experiment of chemical hydrolysis. The polysac-
charide (216 mg∙L-1) was incubated in the standard growth
medium at pH = 5 and pH = 6 for 16 h. The temperature
was kept constant at 37°C and agitation was set to 200
rpm. Samples were collected after 3, 6 and 16h of incuba-
tion and analysed by capillary electrophoresis.
Quantification of CPS, LPS and UDP-sugars
Broth samples were collected from shake flask and fer-
mentation experiments and centrifuged at 1700xg. Super-
natants were then ultrafiltered on 10 KDa centrifugal filter
devices (YM-10 Centricon, Millipore, Bedford, MA, USA)
at 5000xg and concentrated to 1/10th of their initial vol-
ume. The retentate was twice diafiltered and then analyzed
for the content of K4 polysaccharide and LPS.
Capillary electrophoresis analysis were performed on a
Beckman-Coulter HPCE instrument (P/ACE MDQ, Palo
Alto, CA, USA) equipped with a diode array detector
and a UV lamp, using an uncoated fused-silica tube (70
cm of total length, 60 cm of effective length, 50 μm I.D.)at 25°C. Separation and quantification of the K4 and K4
defructosylated polysaccharides and of the O-chain and
LPS were performed according to the previously de-
scribed method [31]. The same equipment was used for
the determination of UDP-sugar concentrations by
slightly modifying the method reported by Xu and col-
leagues [32]. In particular a buffer containing sodium
phosphate 50mM, SDS 60mM and sodium borate
20mM, pH 9 was used for analysing the samples. Runs
were performed at 18°C and 22 kV. UDP-Glu, UDP-
GalNAc and UDP-GlcA were detected at λ = 200 nm.
The concentration of standards used for the construc-
tion of calibration curves ranged between 0.013 to 1.7
mM for UDP-Glu and UDP-GalNAc, and from 0.026 to
1.7 mM for UDP-GlcA. Due to the complexity of the
samples co-elutions with the pure standards were also
performed to ascertain the identity of the different
precursors.
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